Avricore Health Inc.
AVCRF
$0.03
$0.00-3.82%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.90K | 27.40K | 20.70K | 20.70K | 302.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.90K | 27.40K | 20.70K | 20.70K | 302.40K |
| Cost of Revenue | 38.00K | 65.50K | 55.50K | 55.50K | 61.20K |
| Gross Profit | -6.20K | -38.20K | -34.80K | -34.80K | 241.30K |
| SG&A Expenses | 160.50K | 231.10K | 290.10K | 290.10K | 287.50K |
| Depreciation & Amortization | 3.10K | 1.00K | 800.00 | 800.00 | 800.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 201.60K | 297.60K | 346.40K | 346.40K | 349.50K |
| Operating Income | -169.70K | -270.30K | -325.70K | -325.70K | -47.00K |
| Income Before Tax | -147.30K | -275.40K | -331.80K | -331.80K | -53.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -147.30K | -275.40K | -331.80K | -331.80K | -53.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -147.30K | -275.40K | -331.80K | -331.80K | -53.90K |
| EBIT | -169.70K | -270.30K | -325.70K | -325.70K | -47.00K |
| EBITDA | -158.20K | -237.70K | -295.40K | -295.40K | -19.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 101.29M | 101.29M | 101.29M | 101.29M | 101.29M |
| Average Diluted Shares Outstanding | 101.29M | 101.29M | 101.29M | 101.29M | 101.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |